StockData
RVRCOTCPharmaceutical PreparationsFiscal year ends December 31

Revium Rx.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.43+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$86.84M
P/E (TTM)
–
Dividend yield
–

Revium Rx. statistics

Financials through Jun 30, 2026, price as of Oct 16, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureRevium Rx.Industry median
Market Cap$86.84M$166.30M
Enterprise Value$86.00M$88.19M
PB Ratio15.742.03
P/TBV Ratio194.282.29

Income (trailing twelve months)

MeasureRevium Rx.Industry median
Net Income-$13.45M-$22.46M
EPS (Diluted)-$0.22-$0.83

Returns

MeasureRevium Rx.Industry median
Return on Equity (ROE)-243.7%-53.2%
Return on Assets (ROA)-189.2%-40.9%

Balance sheet

MeasureRevium Rx.Industry median
Cash & Short-Term Investments$842.00K$61.43M
Net Cash (Debt)$842.00K$15.35M
Net Cash Per Share$0.01$0.66
Equity (Book Value)$5.52M$49.09M
Book Value Per Share$0.09$1.37
Tangible Book Value$447.00K$23.52M
Working Capital$885.00K$76.81M

Financial position

MeasureRevium Rx.Industry median
Current Ratio1.913.34
Quick Ratio0.872.44

Dividends and yields

MeasureRevium Rx.Industry median
Earnings Yield-15.5%-23.3%

Shares

MeasureRevium Rx.Industry median
Shares Outstanding60,729,10058,127,000
Shares Change (QoQ)0.00%0.54%
Float60,729,10049,136,700
Shares Held by Insiders0.00%11.6%

Taxes

MeasureRevium Rx.Industry median
Income Tax$358.00K$79.87K

Scores

MeasureRevium Rx.Industry median
Altman Z-Score27.71-0.22

Calculated by StockData from Revium Rx.'s SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.